PhytoMulti Capsules

PhytoMulti Capsules

Metagenics4.7 (35 ratings)
Format:Capsule Quantity: 60 Capsule(s) · 20 servings
Goals
$41.50 $2.07 per serving

Product analysis

45 out of 100

PhytoMulti Capsules offers broad nutrient support for normal skin and body functions, particularly when intake is low. An unidentified blend makes the full contents harder to check.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality35

Many nutrient forms are named, but their quality remains uncertain. An unidentified blend and undisclosed source proportions prevent a full comparison of the mixture.

Ingredient Transparency73

All listed amounts and most forms are disclosed, making the main nutrients easier to check. Blend components and the proportions of mixed vitamin sources are undisclosed, leaving parts of the formula unclear.

Value For Money38

The full serving is expensive when considered as a source of lycopene. Value for most other nutrients remains uncertain.

Customer Satisfaction70

Customer ratings are positive. The very small number of responses leaves the wider pattern of satisfaction uncertain.

Product Focus10

The clearest use is filling nutrient gaps that affect normal skin and other body functions. Lutein and lycopene servings are below the relevant skin comparisons, and the unidentified blend leaves the broader purpose uncertain.

Format
Capsule
Container
60 Capsule(s)
Per serving
$2.07
Customer rating
4.7 · 35 ratings
Report analysis

Goals

Skin Health
Impact
High effect
C+ Ingredient FitB+ PathwaysA- EvidenceA+ Formulation Logic
Zinc · 15 mgVitamin C · 120 mgResveratrol · 10 mgCopper · 1 mgSelenium · 100 mcgLycopene · 6 mgVitamin E · 67 mg

Vitamin C helps form collagen, zinc supports skin repair, and B vitamins help maintain skin when intake is low. Copper supports connective-tissue cross-linking, but these normal nutrient roles do not establish additional cosmetic benefits with adequate intake. Lutein and lycopene offer limited UV-related evidence, but the declared 6 mg lutein and 6 mg lycopene per serving are below the main study anchors. Green-tea facts remain unresolved.

How this product is rated for Skin Health

Ingredient fit68

Skin-related ingredients are part of a broader formula. Disclosed amounts explain the retained findings, while unresolved ingredient facts limit additional conclusions.
Goal fit
Relevant skin ingredients appear in a broader formula with other actives, giving a partial focus on this goal.
Dose adequacy
Serving amounts provide the retained amount findings; larger amounts do not automatically mean greater skin benefit.

Pathways80

The saved findings concentrate on uv antioxidant defence. This describes the ingredient pattern, not a demonstrated whole-product skin effect.
Depth
The saved findings concentrate on uv antioxidant defence. This describes the ingredient pattern, not a demonstrated whole-product skin effect.
Breadth
Connective-tissue and UV-related pathways reach the coverage threshold; water-binding support remains absent from these findings.

Evidence89

Copper leads the retained evidence finding, but its connective-tissue role does not establish added skin benefit in copper-replete adults.
Evidence strength
Copper leads the retained evidence finding, but its connective-tissue role does not establish added skin benefit in copper-replete adults.
Studied preparation
Retained ingredients meet the preparation check, but the complete formula is not thereby established as equivalent to a skin trial.

Formulation logic100

No partner gaps or conflicts were identified. All retained ingredients meet the amount threshold, without establishing a proven daily skin-treatment regimen.
Partner coverage
The retained ingredients work independently or have their required partner, without demonstrated extra combination benefit.
Conflicts
No conflicts were identified by the evaluated ingredient checks.
Effective doses
All retained ingredients meet the amount threshold, without establishing a proven daily skin-treatment regimen.
Study evidence
Biotin Supportive 10 studies
Copper Supportive 16 studies
Lycopene Supportive 20 studies
Niacin Supportive 61 studies
Selenium Supportive 22 studies
Vitamin A Supportive 106 studies
Vitamin C Supportive 53 studies
Vitamin E Supportive 38 studies
Zinc Supportive 66 studies
Cardiovascular Support
Impact
High effect
C+ Ingredient FitB+ PathwaysB+ EvidenceA+ Formulation Logic
Vitamin K · 120 mcgMagnesium · 40 mgVitamin D · 25 mcgSelenium · 100 mcgVitamin B12 · 200 mcgVitamin B6 · 25 mgVitamin E · 67 mgLycopene · 6 mgFolate · 1360 mcg DFENiacin · 50 mgVitamin C · 120 mg

Thiamin and selenium help fill nutritional gaps when deficiencies threaten heart function. Folate, B6 and B12 participate in homocysteine processing, but lowering that marker does not establish fewer cardiovascular events. Magnesium offers limited, inconsistent vascular-marker support at the declared amount. Lycopene findings are narrow and do not establish general prevention benefits. The broader formula does not establish added cardiovascular protection from its antioxidant or niacin ingredients.

How this product is rated for Cardiovascular Support

Ingredient fit68

The formula contains relevant nutrients alongside ingredients with broader purposes. Amount recognition is uneven; small or unresolved quantities limit the practical contribution.
Goal fit
The formula contains relevant nutrients alongside ingredients with broader purposes.
Dose adequacy
Amount recognition is uneven; small or unresolved quantities limit the practical contribution.

Pathways80

Homocysteine processing is the strongest recorded route; biological and antioxidant roles do not establish fewer cardiovascular events.
Depth
The strongest recorded route is homocysteine clearance, which describes a biological connection rather than demonstrated event prevention.
Breadth
Two routes have substantial recorded coverage; other routes remain weaker or absent.

Evidence83

Evidence is ingredient- and population-specific; normal nutrient functions and marker changes do not establish cardiovascular-event prevention.
Evidence strength
Lycopene supplies the strongest retained evidence recognition, subject to its specific population and outcome limitations.
Studied preparation
The counted ingredients received preparation recognition; this does not establish cardiovascular-event prevention.

Formulation logic100

No required partner is missing, and no matched conflict was found.
Partner coverage
No required partner is missing for the retained ingredient contributions.
Conflicts
No matched formulation conflict was found in the supplied declarations.
Effective doses
All counted ingredients met the saved amount criterion, which is not proof of clinical effectiveness.
Study evidence
Folate Supportive 93 studies
Lycopene Supportive 68 studies
Magnesium Supportive 123 studies
Niacin Supportive 136 studies
Selenium Supportive 107 studies
Vitamin B6 Supportive 35 studies
Vitamin C Supportive 101 studies
Vitamin D Mixed 170 studies
Vitamin E Mixed 79 studies
Vitamin K Supportive 40 studies

Ingredients

IngredientAmount per servingScore
Vitamin A (Mixed Carotenoids, Retinyl Acetate)
3000 mcg
Vitamin C (Ascorbyl Palmitate, Ascorbic Acid)
120 mg
Vitamin D (Cholecalciferol)
25 mcg
Vitamin E (D-Alpha-Tocopheryl Succinate)
67 mg
Vitamin K (Phytonadione)
120 mcg
Thiamine (Thiamine Mononitrate)
25 mg
Riboflavin
15 mg
Niacin (Niacinamide)
50 mg
Vitamin B6 (Pyridoxine Hydrochloride)
25 mg
Folate (Calcium L-5-Methyltetrahydrofolate)
1360 mcg DFE
Vitamin B12 (Methylcobalamin)
200 mcg
Biotin
500 mcg
Pantothenic Acid (Calcium D-Pantothenate)
75 mg
Choline (Choline Bitartrate)
25 mg
Iodine (Potassium Iodide)
150 mcg
Magnesium (Magnesium Citrate)
40 mg
Zinc (Zinc Citrate)
15 mg
Selenium (Selenium Aspartate)
100 mcg
Copper (Copper Citrate)
1 mg
Manganese (Manganese Citrate)
0.5 mg
Chromium (Chromium Polynicotinate)
200 mcg
Molybdenum (Molybdenum Aspartate Complex)
50 mcg
Proprietary Phytonutrient Blend
400 mg
Myo-Inositol
25 mg
Resveratrol (Polygonum cuspidatum root extract)
10 mg 31
Lutein
6 mg
Lycopene
6 mg 70
Zeaxanthin
2 mg
Gluten Free Adults 18–50 Women
Report overview
Lycopene · 6 mg OverallScore70
A+ Composition And Label DisclosureF Commercial Price And Usability
A serving lists 6 mg of lycopene. At the whole-product serving price, the cost works out to about $3.46 per 10 mg of lycopene.
How this ingredient is rated

Composition and Label Disclosure

No additional composition or form criteria were evaluated.

Composition and Label Disclosure100

The serving lists 6 mg of lycopene.
Declared Active Lycopene Amount
The lycopene amount is listed as 6 mg per serving.

Commercial Price and Usability10

At the whole-product serving price, the cost works out to about $3.46 per 10 mg of lycopene.
Whole-Product Cost per 10 mg Declared Active Lycopene
At the whole-product serving price, the cost works out to about $3.46 per 10 mg of lycopene.
F Composition And Label DisclosureD- Composition And Label DisclosureF Commercial Price And Usability
A serving lists 10 mg of resveratrol, but the saved facts do not identify its trans-resveratrol amount. Without that amount, a price comparison per 250 mg of trans-resveratrol is unavailable.
How this ingredient is rated

Composition and Label Disclosure37

The saved facts identify resveratrol but do not establish the trans form or its concentration in the source.
Explicit Label Detail
Resveratrol is identified, but the saved facts do not establish whether it is the trans form.
Trans-Resveratrol Concentration Disclosure
The saved facts do not specify the concentration of trans-resveratrol in the source.

Composition and Label Disclosure40

A serving lists 10 mg of resveratrol, but a specific trans-resveratrol amount is not established.
Resveratrol Amount Disclosure
A serving lists 10 mg of resveratrol, but a specific trans-resveratrol amount is not established.

Commercial Price and Usability0

The whole-product serving price is known, but the trans-resveratrol amount is unavailable, so its price per 250 mg cannot be calculated.
Cost per 250 mg Declared Trans-Resveratrol
The whole-product serving price is known, but the trans-resveratrol amount is unavailable, so its price per 250 mg cannot be calculated.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Associations of dietary folate, vitamin B6 and B12 intake with cardiovascular outcomes in 115664 participants: a large UK population-based cohort.
    Zhang B; Dong H; Xu Y; Xu D; Sun H; Han L · European journal of clinical nutrition · 2023
    Cohort study115,664 participantsCardiovascular Support forFolate
  2. Folate, Homocysteine, and Adverse Outcomes After Ischemic Stroke.
    Shi M; Zheng J; Liu Y; Mao X; Wu X; Chu M; Niu H; Sun L; Chang X; He Y; Liu Y; Guo D; Zhang Y; Zhu Z; Zhao J · Journal of the American Heart Association · 2024
    Cohort study3,530 participantsCardiovascular Support forFolate
  3. Effect of folic acid on endothelial function following acute myocardial infarction.
    Moens AL; Claeys MJ; Wuyts FL; Goovaerts I; Van Hertbruggen E; Wendelen LC; Van Hoof VO; Vrints CJ · The American journal of cardiology · 2007
    Randomized trial40 participantsCardiovascular Support forFolate
  4. Folic acid enhances endothelial function and reduces blood pressure in smokers: a randomized controlled trial.
    Mangoni AA; Sherwood RA; Swift CG; Jackson SH · Journal of internal medicine · 2003
    Randomized trial24 participantsCardiovascular Support forFolate
  5. 5-methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia.
    Verhaar MC; Wever RM; Kastelein JJ; van Dam T; Koomans HA; Rabelink TJ · Circulation · 1998
    Non-randomized trial20 participantsCardiovascular Support forFolate
  6. Effects of lycopene intake on HDL-cholesterol and triglyceride levels: A systematic review with meta-analysis.
    Inoue T; Yoshida K; Sasaki E; Aizawa K; Kamioka H · Journal of food science · 2021
    Meta-analysis854 participants11 studies pooledCardiovascular Support forLycopene
  7. Improvement of vascular endothelial function by intake of lycopene-rich tomato juice in healthy adults: a randomized, placebo-controlled, double-blind, parallel-group comparative study.
    Yoshida K; Nakazawa Y; Takahashi S; Suzuki S · Food & function · 2025
    Randomized trial75 participantsCardiovascular Support forLycopene
  8. Tomato and lycopene supplementation and cardiovascular risk factors: A systematic review and meta-analysis.
    Cheng HM; Koutsidis G; Lodge JK; Ashor A; Siervo M; Lara J · Atherosclerosis · 2017
    Meta-analysis21 studies pooledCardiovascular Support forLycopene
  9. Lycopene and tomato and risk of cardiovascular diseases: A systematic review and meta-analysis of epidemiological evidence.
    Cheng HM; Koutsidis G; Lodge JK; Ashor AW; Siervo M; Lara J · Critical reviews in food science and nutrition · 2019
    Meta-analysis25 studies pooledCardiovascular Support forLycopene
  10. Lycopene and risk of cardiovascular diseases: A meta-analysis of observational studies.
    Song B; Liu K; Gao Y; Zhao L; Fang H; Li Y; Pei L; Xu Y · Molecular nutrition & food research · 2018
    Meta-analysis14 studies pooledCardiovascular Support forLycopene
  11. Circulating and dietary magnesium and risk of cardiovascular disease: a systematic review and meta-analysis of prospective studies.
    Del Gobbo LC; Imamura F; Wu JH; de Oliveira Otto MC; Chiuve SE; Mozaffarian D · The American journal of clinical nutrition · 2013
    Meta-analysis313,041 participants16 studies pooledCardiovascular Support forMagnesium
  12. Magnesium and the risk of cardiovascular events: a meta-analysis of prospective cohort studies.
    Qu X; Jin F; Hao Y; Li H; Tang T; Wang H; Yan W; Dai K · PloS one · 2013
    Meta-analysis532,979 participants19 studies pooledCardiovascular Support forMagnesium
  13. Quantitative Association Between Serum/Dietary Magnesium and Cardiovascular Disease/Coronary Heart Disease Risk: A Dose-Response Meta-analysis of Prospective Cohort Studies.
    Zhao L; Hu M; Yang L; Xu H; Song W; Qian Y; Zhao M · Journal of cardiovascular pharmacology · 2020
    Meta-analysis544,581 participants18 studies pooledCardiovascular Support forMagnesium
  14. Comparative Efficacy of Nutraceuticals on Endothelial Function: A Systematic Review and Network Meta-Analysis.
    Norouzzadeh M; Rashedi MH; Mahdavi-Mazdeh G; Kosari A; Shahinfar H · Current atherosclerosis reports · 2026
    Meta-analysisCardiovascular Support forMagnesium Cardiovascular Support forVitamin D
  15. Serum magnesium, mortality, and cardiovascular disease in chronic kidney disease and end-stage renal disease patients: a systematic review and meta-analysis.
    Xiong J; He T; Wang M; Nie L; Zhang Y; Wang Y; Huang Y; Feng B; Zhang J; Zhao J · Journal of nephrology · 2020
    Meta-analysis200,934 participants20 studies pooledCardiovascular Support forMagnesium
  16. The current state of niacin in cardiovascular disease prevention: a systematic review and meta-regression.
    Lavigne PM; Karas RH · Journal of the American College of Cardiology · 2013
    Meta-analysis9,959 participants11 studies pooledCardiovascular Support forNiacin
  17. Effects of niacin on apo A1 and B levels: a systematic review and meta-analysis of randomised controlled trials.
    Saboori S; Yousefi Rad E; Tammam J; Thondre PS; Coe S · The British journal of nutrition · 2024
    Meta-analysis12 studies pooledCardiovascular Support forNiacin
  18. Effect of lipid-lowering therapies on lipoprotein(a) levels: a comprehensive meta-analysis of randomized controlled trials.
    Xie S; Galimberti F; Olmastroni E; Carugo S; Catapano AL; Casula M; META-LIPID Group · Atherosclerosis · 2025
    Meta-analysis145,314 participants147 studies pooledCardiovascular Support forNiacin
  19. Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol. Niaspan-Gemfibrozil Study Group.
    Guyton JR; Blazing MA; Hagar J; Kashyap ML; Knopp RH; McKenney JM; Nash DT; Nash SD · Archives of internal medicine · 2000
    Randomized trial173 participantsCardiovascular Support forNiacin
  20. Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemia.
    Knopp RH; Alagona P; Davidson M; Goldberg AC; Kafonek SD; Kashyap M; Sprecher D; Superko HR; Jenkins S; Marcovina S · Metabolism: clinical and experimental · 1998
    Randomized trial223 participantsCardiovascular Support forNiacin